Century Therapeutics (IPSC) Intangibles (2021 - 2026)

Century Therapeutics (IPSC) has reported Intangibles for 4 consecutive years, with $34.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Intangibles changed 0.0% year-over-year to $34.2 million; the TTM figure through Mar 2026 stood at $34.2 million (changed 0.0% YoY), while the FY2025 annual figure was $34.2 million, changed 0.0% from the prior year.
• Intangibles was little changed at $34.2 million in Q1 2026 per IPSC's latest filing, from $34.2 million in the prior quarter.
• Across five years, Intangibles topped out at $34.2 million in Q4 2024 and bottomed at $33.3 million in Q2 2024.
• Historically, Intangibles has averaged $34.0 million across 3 years, with a median of $34.2 million in 2024.
• On a YoY basis, Intangibles climbed as much as 2.7% in 2025 and fell as far as 0.0% in 2025.
• Century Therapeutics' Intangibles stood at $34.2 million in 2024, then changed by 0.0% to $34.2 million in 2025, then changed by 0.0% to $34.2 million in 2026.
• Business Quant data shows IPSC's Intangibles at $34.2 million in Q1 2026, $34.2 million in Q4 2025, and $34.2 million in Q3 2025.